Irish Pharma start-up raises €750,000
Irish pharmaceutical start-up Inflection Biosciences has raised €750,000 from private investors as it moves forward with the pre-clinical development of a cutting edge cancer treatment.
The funding deal is the Dublin-based company’s second to date, bringing its total funding to €1.2 million.
The company also recently agreed a separate funding collaboration with the Multiple Myeloma Research Foundation in the United States, one of the world’s leading private funders of research into multiple myeloma – a type of cancer which begins in bone marrow plasma cells.
